1、Life ScienceLife ScienceSalary GuideSalary Guide2022 Mainland2022 M1The global talent solutions providerThe global talent solutions providerA spectrum of flexible and innovative services with one common goal:to give you a competitive edge in the new world of work.Talent acquisitionTalent acquisition

2、Talent consultingTalent consultingWhatever your needs,we have the expertise,experience and know-how to help you find the best talent more effectively.We help you to better understand your people,their potential and leadership at the individual,group and organisational level.Recruitment of junior to

3、mid-level positions for both temporary and permanent roles Recruitment of experts and directors for strategic business roles Interim management and critical business hires Assessment for selection and development Effective leadership and talent strategies Bespoke predictive modelling Coaching Outpla

4、cement2Morgan Philips Group Salary Guide 2022Morgan Philips Group Salary Guide 20223IntroIntroSince 2013,Morgan Philips Group has built an international platform that disrupts conventional Since 2013,Morgan Philips Group has built an international platform that disrupts conventional thinking in tale

5、nt acquisition and talent consulting thinking in talent acquisition and talent consulting covering the whole spectrum of talent.covering the whole spectrum of talent.countries/regions across 4 continents20+20+global employees500+500+global databaseof talent1 1coachesworldwide 60+60+experts from Club

6、 50005,000+5,000+face to face assessments for selection&development3,000+3,000+onlinepsychometricassessmentsper year 5,000+5,000+talent researchcentres4 4This salary and jobs guide has been compiled by our Life Science Recruitment experts.The figures are based on thousands of candidate interviews co

7、nducted by our specialists and the client assignments weve taken on over the past 12 months.This report uses data and research findings from our own database,different job boards and social networks.For each role,we highlight the number of candidates by geography,seniority,educational background,ave

8、rage tenure,job changes and trends.Clearly,the number doesnt equate to the total number of the specialism roles in Mainland China.4Morgan Philips Group Salary Guide 2022MethodologyMethodologyMorgan Philips Group Salary Guide 20225In recent years,along with the reform of the pharmaceutical review and

9、 approval system,the enthusiasm for innovation in Chinas pharmaceutical industry has been ignited,and a large number of outstanding biopharmaceutical companies have emerged,which in turn has promoted the development and progress of the entire pharmaceutical industry.In terms of policy,NMPA has accel

10、erated the approval process for clinical trial applications and new drug marketing applications to create a favorable regulatory environment for new drug development.Local governments implementing central policies and supplementing them to build the unique advantages of each region in the pharmaceut

11、ical industry.In terms of talent,China is rapidly gathering top academic talent,the vast majority of whom are returnees with overseas academic backgrounds,and these individuals have become the driving force behind Chinas pharmaceutical innovation.Chinas dynamic landscape of innovative drug candidate

12、s is increasingly giving rise to marketed products.Continued efforts by all practitioners are needed to actively and effectively guide the industry in a positive direction,to facilitate the development of durable innovative therapies and to protect patients and meet clinical needs!IntroductionIntrod

13、uctionMorgan Philips Group Salary Guide 20226Top TakeawaysTop TakeawaysHow to crack the difficulty of going to sea for local pharmaceutical companies when innovative drugs are frustrated one after anotherFrom the current situation of enterprises going to sea,domestic biopharmaceutical enterprises go

14、ing to sea is not smooth,the globalization strategy of innovative pharmaceutical enterprises going to sea should focus on good product pipeline.Secondly,drug development should be based on the principle of the earliest intervention in the international,rather than thinking about internationalization

15、 only when it comes to market.In addition,build the corresponding clinical operation team overseas at an early stage of layout,create a professional research team locally,and communicate directly with FDA will be the same important.In general,the development of Chinese innovative drugs towards globa

16、lization is the way to go,but at the same time,understanding the international market situation,making up for their own shortcomings and seeking strong external partners will be important strategies for the development of innovative drug companies.Innovative therapies become a hot spot for drug comp

17、anies to developSome data show that in 2021,the FDA approved a total of 50 innovative therapies(compared to 53 in the same period last year).This is due to the fact that innovative therapies are more likely to be granted special eligibility by the FDA,which can speed up the review of therapies;as we

18、ll as innovative therapies are precision therapies for treating patients carrying specific genetic variants,which have better efficacy and can benefit more patients.Financing in the Chinese biopharmaceutical sector(excluding in vitro diagnostics and testing,etc.)was also very active overall in the j

19、ust-ended quarter,with more than 90 Chinese biopharmaceutical companies completing various rounds and nature of financing.Among them,more than 50 new drug development companies completed early stage financing(Series A/Series A+),thus investment opportunities in the pharmaceutical and health sector w

20、ill continue to be bullish.Among them,novel cell therapies,gene therapy,oncology therapies,and genetic testing will also continue to be of great interest to innovative drug companies.Morgan Philips Group Salary Guide 20227Top TakeawaysTop TakeawaysCXO is still the focus of industry allocationIn 2021

21、,CXOs new orders and orders on hand will be substantial and maintain a high growth rate.Orders,as a core indicator of the companys competitiveness,will add certainty to long-term sustainable development.In 2022,CXOs operating results will continue to show a high growth trend,with many of the results

22、 reaching record highs.Chinese medicine market has huge potential,multinational pharmaceutical companies have entered the layoutNot long ago,the signing ceremony of AstraZenecas Chinese medicine innovation industry base online was held,which attracted the attention of the industry.Behind the many mu

23、ltinational pharmaceutical companies cutting into the Chinese medicine track,analysis believes that this is related to the potential of the Chinese medicine market,especially in the case of chemical drug research and development is weak,multinational pharmaceutical companies would seek a new strateg

24、ic breakthrough.Morgan Philips Group Salary Guide 20228S SummaryummaryPrePre-Clinical/Drug DiscoveryClinical/Drug DiscoveryBiology Director P9Biology Director P9Principle Scientist,Bioinformatics P10 Principle Scientist,Bioinformatics P10 Antibody Discovery Scientist P11Antibody Discovery Scientist

25、P11Senior Scientist,ImmunoSenior Scientist,Immuno-oncology P12oncology P12CMC&Manufacturing CMC&Manufacturing Chemical Manufacturing and Control(Chemical Manufacturing and Control(CMC)CMC)Director P13Director P13Quality Director(GMP)Quality Director(GMP)P14P14Research&Development Research&Developmen

26、t Chief Medical Officer(CMO)P15Chief Medical Officer(CMO)P15Medical Director/Manager P16Medical Director/Manager P16Clinical Operation Director/Manager P17Clinical Operation Director/Manager P17Clinical Quality Director Clinical Quality Director P18P18Director of Biometrics P19Director of Biometrics

27、 P19Pharmacovigilance(PV)Director/Manager P20Pharmacovigilance(PV)Director/Manager P20Director,BD&External Innovation/Alliance Director,BD&External Innovation/Alliance Management P21Management P21This position will play a key role in identifying the scientific directions of the research team for the

28、 next breakthrough therapeutics in close partnership with the CSO,the head of chemistry,and scientific advisors.The ideal candidate will have a thorough understanding of all the requirements and processes needed to advance projects through discovery and development,;A demonstrated track record of le

29、ading research groups that have moved compounds into the clinic is essential.ObjectivesObjectivesJuniorJuniorBiology DirectorBiology DirectorSalaires Salaires(RMB)(RMB)ExperiencedExperiencedSeniorSenior69+69+in Mainland Chinain Mainland China93434Regional BreakdownRegional Breakdown9 97 74 42 2Shang

30、haiShanghaiJiangsuJiangsuBeijingBeijingGuangdongGuangdongSichuanSichuanVariable salaries according to size of employer,Comp&Ben structure and local market900K-1M1M-1.5M1.5M-1.8MBachelorBachelorPhDPhD1919%MasterMaster5 5%76%76%EducationEducationTrendTrendT Turnurn-overoverTenureTenuremedian tenuremed

31、ian tenureTime when these professionals are most likely to change employer1.3 1.3 yearyears sJob moves during the last 12 months7 7Change in the total number of professionals between 2021 and 2022-9%9%Act as the key bioinformatics scientist for internal programs to provide in-depth support for new t

32、arget exploration and validation,NGS related experiment design and analysis,clinical biomarker test platform evaluation and vendor selection,omics related clinical biomarker analysisDesigning,developing and deploying robust workflows to analyze high dimensional omics data,with emphasis on single cel

33、l and bulk transcriptome,exome,proteome and CRISPR screens.PhD degree in bioinformatics,computational biology or related fields.ObjectivesObjectivesJuniorJuniorPrinciple Scientist,Bioinformatics Principle Scientist,Bioinformatics Salaires Salaires(RMB)(RMB)ExperiencedExperiencedSeniorSenior57+57+in

34、Mainland Chinain Mainland China101717Regional BreakdownRegional Breakdown15154 44 44 4ShanghaiShanghaiB BeijingeijingJiangsuJiangsuZhejiangZhejiangTianjinTianjinVariable salaries according to size of employer,Comp&Ben structure and local market500K-800K800K-1M1M-1.2MTrendTrendT Turnurn-overoverTenur

35、eTenuremedian tenuremedian tenureTime when these professionals are most likely to change employer3.3 3.3 yearyears sJob moves during the last 12 months3 3Change in the total number of professionals between 2021 and 2022+1414%BachelorBachelorPhDPhD31%31%MasterMaster16%16%5353%EducationEducationThe sc

36、ientist is expected to be familiar with antibody discovery technologies,including but not limited to antibody generation from hybridoma/phage display/yeast display/nanobody platform,and also have CRO/outsourcing project management experience;Keep a close watch on the leading-edge developments of the

37、rapeutic antibody and immunotherapy;understand global and local therapeutic antibody markets.ObjectivesObjectivesJuniorJuniorAntibody Discovery Scientist Antibody Discovery Scientist Salaires Salaires(RMB)(RMB)Regional BreakdownRegional BreakdownExperiencedExperiencedSeniorSenior34+34+in Mainland Ch

38、inain Mainland China1124245 52 21 1ShanghaiShanghaiJiangsuJiangsuGuangdongGuangdongZhejiangZhejiangVariable salaries according to size of employer,Comp&Ben structure and local market400K-500k500k-700k700k-900kBachelorBachelorPhDPhD3333%MasterMaster2929%38%38%EducationEducationTrendTrendT Turnurn-ove

39、roverTenureTenuremedian tenuremedian tenureTime when these professionals are most likely to change employer2.22.2 yearyears sJob moves during the last 12 months1 1Change in the total number of professionals between 2021 and 2022-3 3%Perform a broad range of molecular,cellular and immune assays to su

40、pport translational research projects and drug mechanistic studiesDesign and execute experiments under supervision of PhD or master level scientistMaintain precise experimental records and lab notesAnalyze data and organize results into a finished format for presentationObjectivesObjectivesJuniorJun

41、iorSenior Scientist,ImmunoSenior Scientist,Immuno-oncologyoncologySalaires Salaires(RMB)(RMB)ExperiencedExperiencedSeniorSenior6868+in Mainland China+in Mainland China124141Regional BreakdownRegional Breakdown9 98 81 11 1ShanghaiShanghaiJiangsuJiangsuBeijingBeijingChongqingChongqingGuangdongGuangdon

42、gVariable salaries according to size of employer,Comp&Ben structure and local market500K-600k600k-700k700k-800kTrendTrendT Turnurn-overoverTenureTenuremedian tenuremedian tenureTime when these professionals are most likely to change employer1 1 yearyearJob moves during the last 12 months9 9Change in

43、 the total number of professionals between 2021 and 2022-8 8%BachelorBachelorPhDPhD23%23%MasterMaster9%9%68%68%EducationEducation3939ObjectivesObjectivesJuniorJuniorChemical Manufacturing and Control(CMC)Director Chemical Manufacturing and Control(CMC)Director Salaires Salaires(RMB)(RMB)Regional Bre

44、akdownRegional BreakdownExperiencedExperiencedSeniorSenior1 12020+in Mainland China+in Mainland China27 713Serves as the primary liaison between the Program Core Team and the CMC Team/Technical OperationsDevelops and oversees execution of integrated project plans including milestones,time

45、lines,resources and budgets.Broad understanding of all aspects of CMC including process development,regulatory and quality requirements,analytical development,formulation and drug product technologies,distribution across multiple regions.ShanghaiShanghaiGuangdongGuangdongJiangsuJiangsuBeijingBeijing

46、ZhejiangZhejiangVariable salaries according to size of employer,Comp&Ben structure and local market900K-1.3M1.3M-2M2M-3.8MBachelorBachelorPhDPhD3232%MasterMaster4242%26%26%EducationEducationTrendTrendT Turnurn-overoverTenureTenuremedian tenuremedian tenureTime when these professionals are most likel

47、y to change employer1.1 1.1 yearyears sJob moves during the last 12 months9 9Change in the total number of professionals between 2021 and 2022+6%+6%Play a key role in setting strategic direction for quality and compliance across the sites,and will assume a key role to drive and support the quality c

48、ulture in close collaboration with stakeholders to ensure that the quality of products and processes are compliant with external and internal GMP requirements.Act as a Responsible Person for any site audits,regulatory inspects on site,as well as overseas audits from authorities or clients.4646Object

49、ivesObjectivesJuniorJuniorQuality Director(GMP)Quality Director(GMP)Salaires Salaires(RMB)(RMB)Regional BreakdownRegional BreakdownExperiencedExperiencedSeniorSenior181181+in Mainland China+in Mainland China272722221818171714ShanghaiShanghaiGuangdongGuangdongJ JiangsuiangsuZhejiangZhejiangBeijingBei

50、jingVariable salaries according to size of employer,Comp&Ben structure and local market800K-1M1M-1.2M1.2M-1.5MBachelorBachelorPhDPhD50%50%MasterMaster4444%EducationEducation6 6%TrendTrendT Turnurn-overoverTenureTenuremedian tenuremedian tenureTime when these professionals are most likely to change e

51、mployer2 2.5.5 yearyears sJob moves during the last 12 months1010Change in the total number of professionals between 2021 and 2022-2%2%7272ObjectivesObjectivesJuniorJuniorSalaires Salaires(RMB)(RMB)Regional BreakdownRegional BreakdownExperiencedExperiencedSeniorSenior3 37 716165 53 315Provide leader

52、ship and direction for companys pipeline of clinical development programs in related therapeutic areas.Will be one of the key senior leaders,expected to provide medical insight,expertise,and determine clinical development strategies and deliveries that leading to the approval of products in China.Sh

53、anghaiShanghaiB BeijingeijingGuangdongGuangdongZhejiangZhejiangHubeiHubeiVariable salaries according to size of employer,Comp&Ben structure and local market1.5-2M2M-2.5M2.5M-3M+TrendTrendT Turnurn-overoverTenureTenuremedian tenuremedian tenureTime when these professionals are most likely to change e

54、mployer1 1 yearyearJob moves during the last 12 months1919Change in the total number of professionals between 2021 and 2022+7 7%Chief Chief MedicalMedical OfficerOfficer(CMO)(CMO)153153+in Mainland China+in Mainland ChinaBachelorBachelorPhDPhD1616%MasterMaster5 5%7979%EducationEducationEstablish cli

55、nical development strategies for one or more therapeutical candidates.Conduct multiple clinical studies,and responsible for the clinical trial design.Assist medical leaders in compiling important documents such as clinical strategic plan,clinical research program,and regulatory plan.Participate in a

56、cademic exchanges within and outside the company and discuss and demonstrate clinical research results of products at academic conferences.17251725ObjectivesObjectivesJuniorJuniorSalaires Salaires(RMB)(RMB)Regional BreakdownRegional BreakdownExperiencedExperiencedSeniorSenior9928728727527

57、5216BeijingBeijingShanghaiShanghaiGuangdongGuangdongJiangsuJiangsuShandongShandongVariable salaries according to size of employer,Comp&Ben structure and local market1-1.2M1.2M-1.5M1.5M-2M+TrendTrendT Turnurn-overoverTenureTenuremedian tenuremedian tenureTime when these professionals are most likely

58、to change employer2.42.4 yearyearJob moves during the last 12 months261261Change in the total number of professionals between 2021 and 2022+0.3%+0.3%MedicalMedical DirectorDirector/Manager/Manager11714+in Mainland China11714+in Mainland ChinaBachelorBachelorPhDPhD40%40%MasterMaster19%19%4 41 1%Educa

59、tionEducationOversee the implementation of clinical projects and the management of clinical studies to ensure studies are completed on time,in compliance with related regulations,guidelines and SOPs,study protocol,project management plan and monitoring plan.Implement and drive resource strategy for

60、Clinical Operations to meet project deliverables and timelines and changing workloads.ObjectivesObjectivesJuniorJuniorSalaires Salaires(RMB)(RMB)ExperiencedExperiencedSeniorSenior17Variable salaries according to size of employer,Comp&Ben structure and local market800K-1M1M-1.5M1.5M-2M+TrendTrendT Tu

61、rnurn-overoverTenureTenuremedian tenuremedian tenureTime when these professionals are most likely to change employer2.22.2 yearyearJob moves during the last 12 months2222Change in the total number of professionals between 2021 and 2022-2%2%ClinicalClinical OperationOperation DirectorDirector/Manager

62、Manager193+in Mainland China193+in Mainland ChinaBachelorBachelorPhDPhD5656%MasterMaster3737%8 8%EducationEducation7171Regional BreakdownRegional Breakdown676713138 85 5BeijingBeijingShanghaiShanghaiGuangdongGuangdongJiangsuJiangsuSichuanSichuanThe purpose of this position is to be a quality advocat

63、or who works with the management and quality leadership to implement quality management system and drive continuous improvements.Be responsible for Good Clinical Practice(GCP)and/or Good Pharmacovigilance Practice(GVP)oversight,and for assuring the compliance with the company Standard Operating Proc

64、edures(SOPs),Policies,and all applicable worldwide regulations and guidelines if applicable.ObjectivesObjectivesJuniorJuniorSalaires Salaires(RMB)(RMB)ExperiencedExperiencedSeniorSenior18Variable salaries according to size of employer,Comp&Ben structure and local market400-800K800K-1M1-1.5M+TrendTre

65、ndT Turnurn-overoverTenureTenuremedian tenuremedian tenureTime when these professionals are most likely to change employer3.33.3 yearyearJob moves during the last 12 months1 15 5Change in the total number of professionals between 2021 and 2022+9%+9%ClinicalClinical QualityQuality DirectorDirector107

66、+in Mainland China107+in Mainland ChinaBachelorBachelorPhDPhD54%54%MasterMaster43%43%EducationEducation4444Regional BreakdownRegional Breakdown272713138 85 5ShanghaiShanghaiBeijingBeijingJiangsuJiangsuGuangdongGuangdongLiaoningLiaoning2%2%Provide leadership in biostatistics for clinical studies.dire

67、ct the statistics team to deliver reports together with physician and clinical operation,provides trial design,CRF review,data analysis and interpretation and reports on all innovative pipeline interventional clinical studies.Be responsible for holding CRO/Partners accountable for high quality stand

68、ards of their activities and deliverables.ObjectivesObjectivesJuniorJuniorSalaires Salaires(RMB)(RMB)ExperiencedExperiencedSeniorSenior19Variable salaries according to size of employer,Comp&Ben structure and local market800K-1M1M-1.5M1.5M-2M+TrendTrendT Turnurn-overoverTenureTenuremedian tenuremedia

69、n tenureTime when these professionals are most likely to change employer3.53.5 yearyearJob moves during the last 12 months2 2Change in the total number of professionals between 2021 and 2022+2%+2%Director of BiometricsDirector of Biometrics17+in Mainland China17+in Mainland ChinaBachelorBachelorPhDP

70、hD5 50 0%MasterMaster3030%20%20%EducationEducation6 6Regional BreakdownRegional Breakdown5 51 11 11 1BeijingBeijingShanghaiShanghaiZhejiangZhejiangFujianFujianHubeiHubeiManages the global pharmacovigilance process to ensure compliance with all applicable laws and regulationsEnsures that all safety r

71、eports received from any source are processed and reported according to guidelines,regulatory requirements,and company SOPs and proceduresOversees the system for ICSR collection,processing,reconciliation and reporting,including associated quality and training activities to ensure regulatory timeline

72、s and global standards are metObjectivesObjectivesJuniorJuniorSalaires Salaires(RMB)(RMB)ExperiencedExperiencedSeniorSenior20Variable salaries according to size of employer,Comp&Ben structure and local market400-800K800K-1M1-1.5M+TrendTrendT Turnurn-overoverTenureTenuremedian tenuremedian tenureTime

73、 when these professionals are most likely to change employer2.72.7 yearyearJob moves during the last 12 months2020Change in the total number of professionals between 2021 and 2022+7%+7%Pharmacovigilance(PV)Director/ManagerPharmacovigilance(PV)Director/Manager80+in Mainland China80+in Mainland ChinaB

74、achelorBachelorPhDPhD4444%MasterMaster3 33%3%2323%EducationEducation2 22 2Regional BreakdownRegional Breakdown17176 65 54 4ShanghaiShanghaiBeijingBeijingJiangsuJiangsuLiaoningLiaoningShandongShandongBe responsible for managing and optimizing the value of alliances at all stages of the product life c

75、ycle,from pre-clinical development to commercialization.In accordance with the companys strategy,responsible for the relevant partner communication and coordination.Provide comments for collaboration agreements,maintain and optimize the relationship with the partners,timely communicate the informati

76、on related to both parties,and ensure the timely completion of projects under the partner agreement and timely receipt and payment of contract payments.ObjectivesObjectivesJuniorJuniorSalaires Salaires(RMB)(RMB)ExperiencedExperiencedSeniorSenior21Variable salaries according to size of employer,Comp&

77、Ben structure and local market1-1.5M1.5-2M2-3M+TrendTrendT Turnurn-overoverTenureTenuremedian tenuremedian tenureTime when these professionals are most likely to change employer2.32.3 yearyearJob moves during the last 12 months8484Change in the total number of professionals between 2021 and 2022+6%+

78、6%DirectorDirector,BD&,BD&ExternalExternal Innovation/Alliance ManagementInnovation/Alliance Management 661661+in Mainland China+in Mainland ChinaBachelorBachelorPhDPhD5 57%7%MasterMaster20%20%2323%EducationEducation293293Regional BreakdownRegional Breakdown8382727ShanghaiShanghaiBeijingB

79、eijingGuangdongGuangdongJiangsuJiangsuZhejiangZhejiangRecruitment Experts in LRecruitment Experts in Life Scienceife Science22Morgan Philips Group Salary Guide 2022S Sophie Fanophie FDirectorLife ScienceMay HanMay HSenior ConsultantLife ScienceWWendy Xuendy XManagerLife ScienceContact Us:Contact Us: Shanghai+86 21 3103 2210Beijing+86 21 3103 2210Guangzhou+86 20 6287 4959Shenzhen+86 755 6661 3163 Morgan Philips Group 2022.All rights reserved.23